![](/img/cover-not-exists.png)
2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer
Houede, N., Roubaud, G., Mahammedi, H., Vedrine, L., Joly, F., Mourey, L., Pfister, C., Culine, S., Goberna, A., Lortal, B., Pulido, M., Pourquier, P., Bellera, C.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31412-5
Date:
September, 2015
File:
PDF, 58 KB
english, 2015